• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺功能不全——识别与管理。

Adrenal insufficiency - recognition and management.

作者信息

Pazderska Agnieszka, Pearce Simon Hs

机构信息

Department of Endocrinology, St James's Hospital Dublin, Ireland.

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK

出版信息

Clin Med (Lond). 2017 Jun;17(3):258-262. doi: 10.7861/clinmedicine.17-3-258.

DOI:10.7861/clinmedicine.17-3-258
PMID:28572228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6297573/
Abstract

Adrenal insufficiency is characterised by inadequate -glucocorticoid production owing to destruction of the adrenal cortex or lack of adrenocorticotropic hormone stimulation. In primary adrenal insufficiency, lack of mineralocorticoids is also a feature. Patients can present with an insidious onset of symptoms, or acutely in adrenal crisis, which requires prompt recognition and treatment. Chronic glucocorticoid therapy is the most common cause of adrenal insufficiency. The -diagnosis of adrenal insufficiency is made by -demonstrating low basal and/or stimulated serum cortisol and should be -followed by appropriate investigations to establish the -underlying aetiology. Maintenance glucocorticoid -replacement is usually given as a twice or thrice daily hydrocortisone preparation. Patients with primary adrenal insufficiency also require mineralocorticoid. Regular monitoring for features of under- and over- replacement is essential during follow-up. Patient education is a key feature of management of this condition.

摘要

肾上腺功能不全的特征是由于肾上腺皮质破坏或缺乏促肾上腺皮质激素刺激导致糖皮质激素分泌不足。在原发性肾上腺功能不全中,盐皮质激素缺乏也是一个特征。患者可能症状隐匿起病,或在肾上腺危象时急性起病,这需要及时识别和治疗。慢性糖皮质激素治疗是肾上腺功能不全最常见的原因。肾上腺功能不全的诊断是通过证明基础和/或刺激后的血清皮质醇水平低来做出的,并且应该随后进行适当的检查以确定潜在病因。维持性糖皮质激素替代通常给予每日两次或三次的氢化可的松制剂。原发性肾上腺功能不全的患者也需要盐皮质激素。在随访期间,定期监测替代不足和过量的特征至关重要。患者教育是这种疾病管理的一个关键特征。

相似文献

1
Adrenal insufficiency - recognition and management.肾上腺功能不全——识别与管理。
Clin Med (Lond). 2017 Jun;17(3):258-262. doi: 10.7861/clinmedicine.17-3-258.
2
Diagnosis and management of adrenal insufficiency.肾上腺功能不全的诊断与治疗。
Clin Med (Lond). 2023 Mar;23(2):115-118. doi: 10.7861/clinmed.2023-0067.
3
Adrenal insufficiency.肾上腺功能不全。
J Clin Pathol. 2022 Jul;75(7):435-442. doi: 10.1136/jclinpath-2021-207895. Epub 2022 May 9.
4
The management of glucocorticoid deficiency: Current and future perspectives.糖皮质激素缺乏症的管理:当前和未来的观点。
Clin Chim Acta. 2020 Jun;505:148-159. doi: 10.1016/j.cca.2020.03.006. Epub 2020 Mar 5.
5
[CME: Adrenal Insufficiency].[继续医学教育:肾上腺功能不全]
Praxis (Bern 1994). 2018 Jun;107(13):717-725. doi: 10.1024/1661-8157/a002982.
6
[Primary and secondary adrenal insufficiency in adults].[成人原发性和继发性肾上腺皮质功能减退症]
Rev Prat. 2008 May 15;58(9):949-56.
7
SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook.SFE/SFEDP 肾上腺皮质功能减退症法国共识:引言与手册。
Ann Endocrinol (Paris). 2018 Feb;79(1):1-22. doi: 10.1016/j.ando.2017.12.001. Epub 2018 Jan 12.
8
Isolated corticotrophin deficiency.孤立性促肾上腺皮质激素缺乏症
Pituitary. 2006;9(4):289-95. doi: 10.1007/s11102-006-0408-5.
9
Hypoglycaemia in adrenal insufficiency.肾上腺功能不全时的低血糖症。
Front Endocrinol (Lausanne). 2023 Nov 20;14:1198519. doi: 10.3389/fendo.2023.1198519. eCollection 2023.
10
Primary adrenal insufficiency in children: Diagnosis and management.儿童原发性肾上腺皮质功能减退症:诊断与治疗。
Best Pract Res Clin Endocrinol Metab. 2018 Aug;32(4):397-424. doi: 10.1016/j.beem.2018.05.010. Epub 2018 Jun 6.

引用本文的文献

1
Mineralocorticoid effects of fludrocortisone and hydrocortisone in primary adrenal insufficiency: EU-AIR patient data.氟氢可的松和氢化可的松在原发性肾上腺皮质功能不全中的盐皮质激素作用:欧盟肾上腺皮质功能不全注册研究患者数据
J Endocrinol Invest. 2025 Sep 6. doi: 10.1007/s40618-025-02657-7.
2
A case of adrenal insufficiency presenting with seizures, complicated by developmental cerebral venous anomaly and Takotsubo cardiomyopathy: a case report.一例以癫痫发作为表现的肾上腺功能不全病例,并发大脑发育性静脉异常和Takotsubo心肌病:病例报告
J Med Case Rep. 2025 Aug 21;19(1):424. doi: 10.1186/s13256-025-05463-0.
3
Micro- and Nanoplastics as Disruptors of the Endocrine System-A Review of the Threats and Consequences Associated with Plastic Exposure.微塑料和纳米塑料对内分泌系统的干扰——塑料暴露相关威胁与后果综述
Int J Mol Sci. 2025 Jun 26;26(13):6156. doi: 10.3390/ijms26136156.
4
Shock in the post-operative ICU: the etomidate enigma.术后重症监护病房中的休克:依托咪酯之谜。
Anaesthesiol Intensive Ther. 2025 Jul 4;57(1):136-138. doi: 10.5114/ait/200293.
5
Comparison of prednisolone and alternative glucocorticoid dosing protocols for canine hypoadrenocorticism: insights from a survey-based study.泼尼松龙与替代糖皮质激素给药方案治疗犬肾上腺皮质功能减退症的比较:一项基于调查研究的见解
Front Vet Sci. 2025 Apr 14;12:1544750. doi: 10.3389/fvets.2025.1544750. eCollection 2025.
6
Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations.奥西卓司他治疗肾上腺性和异位库欣综合征:临床研究与病例报告的整合
J Endocr Soc. 2025 Feb 14;9(4):bvaf027. doi: 10.1210/jendso/bvaf027. eCollection 2025 Mar 3.
7
Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma.口服皮质类固醇的使用经验及不良反应:一项针对哮喘患者的全国横断面调查。
Patient Prefer Adherence. 2025 Jan 10;19:75-85. doi: 10.2147/PPA.S487743. eCollection 2025.
8
Emergencies in Hematology: Why, When and How I Treat?血液学急症:为何、何时以及如何进行治疗?
J Clin Med. 2024 Dec 12;13(24):7572. doi: 10.3390/jcm13247572.
9
Cerebral adrenoleukodystrophy presenting as status epilepticus: Unveiling the neurological maze.以癫痫持续状态为表现的脑肾上腺脑白质营养不良:揭开神经迷宫之谜。
Radiol Case Rep. 2024 Oct 30;20(1):414-418. doi: 10.1016/j.radcr.2024.10.018. eCollection 2025 Jan.
10
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy.糖皮质激素替代治疗在垂体疾病患者中的作用:个性化替代治疗的新视角。
Rev Endocr Metab Disord. 2024 Oct;25(5):855-873. doi: 10.1007/s11154-024-09898-6. Epub 2024 Aug 22.

本文引用的文献

1
Adrenal insufficiency in patients on long-term opioid analgesia.长期使用阿片类镇痛药患者的肾上腺功能不全
Clin Endocrinol (Oxf). 2016 Dec;85(6):831-835. doi: 10.1111/cen.13125. Epub 2016 Jun 28.
2
Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information.肾上腺皮质功能不全的糖皮质激素治疗:不依从性、对信息的担忧与不满
Clin Endocrinol (Oxf). 2016 May;84(5):664-71. doi: 10.1111/cen.12991. Epub 2016 Feb 15.
3
Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.采用双释放氢化可的松治疗艾迪生病患者后人体测量学和代谢参数及生活质量的改善情况。
Endocrine. 2016 Feb;51(2):360-8. doi: 10.1007/s12020-015-0681-z. Epub 2015 Jul 17.
4
Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.缓释氢化可的松可降低原发性和继发性肾上腺皮质功能不全患者的体重指数和糖化血红蛋白水平。
Eur J Endocrinol. 2015 May;172(5):619-26. doi: 10.1530/EJE-14-1114. Epub 2015 Feb 5.
5
A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.一项关于氢化可的松缓释制剂Chronocort治疗成年经典型先天性肾上腺皮质增生症的2期研究。
J Clin Endocrinol Metab. 2015 Mar;100(3):1137-45. doi: 10.1210/jc.2014-3809. Epub 2014 Dec 11.
6
High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study.慢性肾上腺皮质功能减退症患者中肾上腺危象的高发病率:一项前瞻性研究。
J Clin Endocrinol Metab. 2015 Feb;100(2):407-16. doi: 10.1210/jc.2014-3191. Epub 2014 Nov 24.
7
Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.艾迪生病患者的昼夜激素谱与胰岛素敏感性:持续皮下输注氢化可的松与传统糖皮质激素替代疗法的比较
Clin Endocrinol (Oxf). 2015 Jul;83(1):28-35. doi: 10.1111/cen.12670. Epub 2015 Jan 12.
8
Current and emerging therapies for Addison's disease.艾迪生病的现有及新兴疗法。
Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):147-53. doi: 10.1097/MED.0000000000000067.
9
Cardiovascular risk factors in patients with Addison's disease: a comparative study of South African and Swedish patients.艾迪生病患者的心血管危险因素:南非和瑞典患者的比较研究。
PLoS One. 2014 Mar 6;9(6):e90768. doi: 10.1371/journal.pone.0090768. eCollection 2014.
10
Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.持续皮下氢化可的松输注与口服氢化可的松替代治疗艾迪生病:一项随机临床试验。
J Clin Endocrinol Metab. 2014 May;99(5):1665-74. doi: 10.1210/jc.2013-4253. Epub 2014 Feb 11.